| Disaggregation of Revenue [Table Text Block] |
| |
|
Three Months ended June 30,
|
|
|
Six Months ended June 30,
|
|
| |
|
2025
|
|
|
2024
|
|
|
2025
|
|
|
2024
|
|
| |
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
A$
|
|
|
Major product/service lines
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coagulation testing products
|
|
|
587,745 |
|
|
|
799,736 |
|
|
|
1,156,982 |
|
|
|
1,427,728 |
|
|
Laboratory testing services
|
|
|
81,014 |
|
|
|
253,588 |
|
|
|
305,860 |
|
|
|
543,255 |
|
|
Wine testing products
|
|
|
506,565 |
|
|
|
541,683 |
|
|
|
1,199,714 |
|
|
|
1,068,371 |
|
|
Veterinary diabetes products
|
|
|
33,440 |
|
|
|
30,559 |
|
|
|
100,867 |
|
|
|
55,722 |
|
| |
|
|
1,208,764 |
|
|
|
1,625,566 |
|
|
|
2,763,423 |
|
|
|
3,095,076 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Timing of revenue recognition
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Products and services transferred at a point in time
|
|
|
1,208,764 |
|
|
|
1,625,566 |
|
|
|
2,763,423 |
|
|
|
3,095,076 |
|
|
| Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] |
| |
|
June 30, 2025
|
|
|
December 31, 2024
|
|
| |
|
A$
|
|
|
A$
|
|
|
Receivables
|
|
|
722,609 |
|
|
|
956,500 |
|
|
Contract liabilities
|
|
|
10,057 |
|
|
|
4,781 |
|
| |
|
June 30, 2025
|
|
|
December 31, 2024
|
|
| |
|
A$
|
|
|
A$
|
|
|
Contract Liabilities - current:
|
|
|
|
|
|
|
|
|
|
Opening balance
|
|
|
4,781 |
|
|
|
36,132 |
|
|
Closing balance
|
|
|
10,057 |
|
|
|
4,781 |
|
|
Net increase/(decrease)
|
|
|
5,276 |
|
|
|
(31,351 |
) |
|